‹ ›
MYP_151439
← PREVIOUS NEXT → BACK
Basic Information
NS5A-derived peptide C5A [I6L]
Antimicrobial
Antiviral
Antiviral ▸ Anti-Hepatitis virus ▸ Anti-HCV
Antiviral ▸ Anti-HIV ▸ Anti-HIV-1
Antiviral ▸ Anti-HIV ▸ HIV
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition ▸ Entry inhibitor
Enzyme modulation ▸ Enzyme inhibition ▸ Infection inhibition
Toxicity / Safety ▸ Blood cell toxicity ▸ Hemolysis ▸ Hemolytic
Venom / Toxin ▸ General toxin ▸ Toxic
Standard
18 amino acids
C109H155N25O29S
Standard
Sequence
SWLRDLWDWICEVLSDFK
Physicochemical Analysis
2311.61 Da
4.23
-2.54
-2.77
-0.1414
-0.07
0.72
0.10
27.62
102.78
0.2222
16500.00
16500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
882.97
-2.51
33.0
28.0
72.0
164.0
7.0
17.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0309560 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
Hepatitis C virus (HCV)
PMID21801309 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/21801309/
RECORD: Rec_0316015 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
HIV
PMID21801309 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/21801309/
RECORD: Rec_0352638 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral Toxic Hemolytic
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/
RECORD: Rec_0355506 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HIV-1 Infection inhibition
HIV-1 | TZM-BL cells
5 μM
IC50
Mammalian: 1.9 h; Yeast: >20 h; E. coli: >10 h
PaperRational design of peptides with anti-HCV/HIV activities and enhanced specificity. | Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX. | Chem Biol Drug Des. 2011 Nov;78(5):835-43. | DOI:10.1111/j.1747-0285.2011.01201.x | PMID:21801309 PMID21801309 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/21801309/
RECORD: Rec_0420997 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HCV Infection inhibition
HCV | Huh7.5.1 cells
1.4±0.13 μM
IC50
Mammalian: 1.9 h; Yeast: >20 h; E. coli: >10 h
PaperRational design of peptides with anti-HCV/HIV activities and enhanced specificity. | Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX. | Chem Biol Drug Des. 2011 Nov;78(5):835-43. | DOI:10.1111/j.1747-0285.2011.01201.x | PMID:21801309 PMID21801309 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/21801309/
FIRST PREV 1 2 3
Showing 5 records on this page · Page 3 of 3